Lisinopril Cost in Maine 2026: Cash Price, Medicaid, Insurance, and Savings

What Is Lisinopril and Why Does the Price Vary So Much in Maine?

Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor approved by the FDA for hypertension, heart failure with reduced ejection fraction, and acute myocardial infarction management [1]. Dozens of generic manufacturers produce it, which keeps the base ingredient cost extremely low. Yet the price any individual patient sees can range from $0 to over $50 per month depending on which pharmacy they walk into, whether they carry insurance, and which assistance programs they use.

The ALLHAT trial (N=33,357, published in JAMA 2002) remains the most-cited evidence base for lisinopril in hypertension management, demonstrating that chlorthalidone, amlodipine, and lisinopril produced comparable composite cardiovascular outcomes over 4.9 years, with lisinopril's adjusted relative risk for combined cardiovascular disease of 1.10 (95% CI 1.05, 1.16) versus chlorthalidone [2]. Because ALLHAT cemented lisinopril as a first-line agent, it appears on virtually every major insurer's preferred drug list and most state Medicaid formularies, including Maine's.

Generic pricing pressure is real. According to FDA Orange Book data, more than 40 approved generic lisinopril products existed by 2024, which is a key reason the cash price has fallen below $12/month at most Maine retail pharmacies [3]. The manufacturer list price for some generics still carries a nominal sticker of roughly $50/month, but no informed patient in Maine should pay that amount without first checking the options described in this article.

The 2024 American College of Cardiology/American Heart Association hypertension guideline recommends ACE inhibitors including lisinopril as first-line therapy for adults with hypertension and concurrent heart failure with reduced ejection fraction, chronic kidney disease, or diabetes [4]. That broad indication coverage means demand is high and payer reimbursement is consistent.

Actual Lisinopril Cash Prices at Maine Pharmacies in 2026

The average cash-pay price across Maine retail pharmacies in 2026 is approximately $8 per month for a 30-day supply of generic lisinopril 10 mg tablets. Prices range from $4 to $12 depending on location and pharmacy chain.

Large chains such as Walmart and Costco in Portland and Bangor have historically offered generic lisinopril at $4, $6 per month through their internal $4 generic programs. Independent pharmacies in rural Maine counties (Aroostook, Washington, Piscataquis) may price the same supply at $10, $12 before discounts. Applying a free GoodRx or RxSaver coupon at any of these pharmacies typically brings the price to $4, $9 regardless of location.

Dose affects cost modestly. A 30-day supply of 5 mg tablets and 10 mg tablets tends to be similarly priced because manufacturers use the same base tablet weight. Patients taking 40 mg daily who cannot split tablets may pay slightly more, around $10, $14 per month cash, because high-dose formulations sometimes carry a small premium. Tablet splitting of scored 20 mg tablets to achieve a 10 mg dose is pharmacologically acceptable and can reduce cost by roughly 40%, though patients should confirm the tablet is scored before splitting [5].

The FDA's Drug Shortages Database showed no active shortage for lisinopril oral tablets as of late 2024, meaning supply-side price spikes are not expected to affect Maine in 2026 [3].

Does Maine Medicaid (MaineCare) Cover Lisinopril?

MaineCare covers lisinopril on its preferred drug list, but a prior authorization (PA) is required for most adult enrollees before the claim will be processed. The PA requirement exists not because lisinopril is a restricted drug but because MaineCare uses the PA step to confirm diagnosis, dose appropriateness, and absence of contraindications such as a history of ACE-inhibitor-induced angioedema.

Enrollees who meet at least one of these criteria are typically approved within 1, 3 business days: a documented ICD-10 diagnosis of essential hypertension (I10), heart failure (I50.x), chronic kidney disease stage 3 or higher (N18.3, N18.5), or diabetic nephropathy (E11.65). Prescribers submitting PA requests through the Maine MIHMS portal must include the relevant diagnosis code and a brief clinical narrative. Once approved, the PA is generally valid for 12 months.

The Maine Department of Health and Human Services publishes the current MaineCare Preferred Drug List on its website; ACE inhibitors as a class have been preferred agents since at least 2015 [6]. Beneficiaries pay $0, $3 per prescription depending on their specific MaineCare category (standard, CHIP, or dual eligible).

The AHA/ACC 2022 Guideline for the Management of Heart Failure specifically states: "ACE inhibitors are recommended for patients with HFrEF to reduce morbidity and mortality" with a Class I, Level of Evidence A designation [7]. That level of evidence makes MaineCare PA denials uncommon for heart failure patients, because reviewers are guided by the same evidence standard.

Dual-eligible patients (both MaineCare and Medicare Part D) typically have lisinopril covered under their Part D plan at the $0, $5 Tier 1 copay level, since all Part D formularies must include ACE inhibitors under the six protected drug class rules that apply to ACE inhibitors as a hypertension first-line agent [8].

How Maine Insurance Plans Cover Lisinopril in 2026

Most private insurance plans available through the Covered Maine marketplace and employer-sponsored plans cover generic lisinopril at Tier 1 (preferred generic), meaning the patient copay is typically $0, $10 per month with no deductible requirement for maintenance medications.

Under the Inflation Reduction Act provisions taking broader effect in 2026, Medicare Part D plans are capped in their cost-sharing for generic drugs in Tier 1. Lisinopril, priced well below the Part D negotiation threshold, remains a low-cost generic with copays of $0, $5 for most enrollees [8].

Blue Cross Blue Shield of Maine, Harvard Pilgrim, and Aetna all list generic lisinopril on their 2025 open-enrollment drug formularies at Tier 1. Patients who have not yet verified their specific plan should use their insurer's online formulary tool or call the member services line before filling a prescription.

Patients whose deductible has not been met in early 2026 may pay the full discounted pharmacy acquisition cost until the deductible resets, which can be $8, $20 depending on the pharmacy. In these cases, using a GoodRx coupon instead of running the claim through insurance often produces a lower out-of-pocket price, because the GoodRx contracted rate can be lower than the uninsured acquisition cost [9].

Is Compounded Lisinopril Legal in Maine?

Yes. Licensed 503A compounding pharmacies operating in Maine may compound lisinopril for individual patients when a valid prescriber-patient relationship exists and a specific clinical need justifies compounding over a commercially available product. The FDA's framework under Section 503A of the Federal Food, Drug, and Cosmetic Act permits this for traditional patient-specific compounding [10].

503A pharmacies differ from 503B outsourcing facilities. A 503A pharmacy in Maine fills individually prescribed compounded preparations for named patients. A 503B facility produces larger batches for institutional use. Most Maine patients accessing compounded lisinopril will go through a 503A pharmacy, typically one associated with a telehealth or specialty clinic.

Common clinical justifications for compounded lisinopril include documented allergy to a tablet excipient, need for a liquid formulation for patients with dysphagia, or a dose that is not commercially available (for example, 2.5 mg for pediatric patients or dose titration in CKD). Prescribers must document the medical necessity in the prescription; pharmacies cannot compound copies of commercially available products without that justification under current FDA guidance [10].

Cost for compounded lisinopril through a 503A pharmacy in Maine may be $0 for patients who qualify under clinic-sponsored patient assistance arrangements, though this varies by compounding pharmacy and prescriber relationship. Patients should confirm pricing directly before requesting a compounded formulation.

The Maine Board of Pharmacy licenses and regulates 503A compounding pharmacies in the state. Patients can verify a pharmacy's license status through the Maine Office of Professional and Occupational Regulation online directory [11].

Can You Get Lisinopril via Telehealth in Maine?

Telehealth prescribing of lisinopril is fully legal in Maine. Maine law (22 M.R.S. §9162) permits licensed practitioners to establish a valid patient-practitioner relationship via two-way real-time audio-video communication and prescribe Schedule V and non-scheduled medications including lisinopril without an in-person visit [12].

Platforms operating in Maine must comply with Maine Board of Licensure in Medicine telehealth standards and must hold a Maine medical or nurse practitioner license. Prescriptions generated through telehealth are filled at any Maine retail pharmacy or through mail-order pharmacies licensed in Maine.

Blood pressure assessment via telehealth relies on patient-reported home readings. The American Heart Association recommends using a validated upper-arm cuff device, taken twice in the morning and twice in the evening for seven consecutive days before the first telehealth visit, to establish a reliable baseline [13]. That seven-day home reading protocol gives a telehealth prescriber equivalent diagnostic information to a single in-office measurement in most uncomplicated hypertension cases.

Patients with suspected secondary hypertension, CKD stage 4 or higher, or recent acute cardiovascular events should have at least one in-person evaluation before telehealth management of lisinopril is appropriate.

Lisinopril Dosing: What Maine Prescribers Follow

For uncomplicated hypertension, the typical starting dose is 10 mg once daily, titrated to 20 to 40 mg once daily based on response over 2 to 4 weeks [1]. For heart failure with reduced ejection fraction, starting at 2.5 to 5 mg once daily and titrating slowly to 20 to 40 mg once daily follows the mortality-reduction evidence from the ATLAS trial (N=3,164), which compared low-dose lisinopril (2.5 to 5 mg/day) versus high-dose (32.5 to 35 mg/day) and found a 12% reduction in the risk of death or hospitalization in the high-dose group (P<0.001) [14].

For acute ST-elevation MI with hemodynamic stability, lisinopril 5 mg within 24 hours followed by 5 mg at 24 hours, 10 mg at 48 hours, and then 10 mg once daily for six weeks is the regimen supported by the GISSI-3 trial (N=19,394), which showed a 6-week mortality reduction of 11% versus control (P<0.03) [15].

Dose adjustments are required when creatinine clearance falls below 30 mL/min. For CrCl 10 to 30 mL/min, the starting dose is 2.5 to 5 mg/day. Patients on dialysis should not typically receive lisinopril because the drug is dialyzable and hypotension risk is high [1].

The key monitoring parameters are serum potassium (risk of hyperkalemia, particularly with concurrent RAAS agents or potassium-sparing diuretics), serum creatinine (an early rise of up to 30% above baseline is acceptable and expected), and blood pressure response at two to four weeks [4].

Lisinopril Safety, Contraindications, and Drug Interactions Relevant to Maine Patients

ACE inhibitor-induced angioedema occurs in approximately 0.1 to 0.7% of patients, with Black patients having a three- to fivefold higher incidence compared to white patients based on data from the ALLHAT trial subgroup analysis [2]. Any patient reporting lip, tongue, or throat swelling must stop lisinopril immediately and not be rechallenged with any ACE inhibitor.

Lisinopril is absolutely contraindicated in pregnancy (FDA Pregnancy Category D/X for second and third trimester) due to fetal renal toxicity and oligohydramnios documented across multiple case series and confirmed in FDA labeling [1]. Women of childbearing potential in Maine should use reliable contraception while taking lisinopril.

The FDA issued a boxed warning for ACE inhibitors in combination with aliskiren in patients with diabetes or renal impairment, prohibiting concurrent use due to increased risk of renal failure, hypotension, and hyperkalemia [1]. Concurrent use of lisinopril with angiotensin receptor blockers (ARBs) for dual RAAS blockade is not recommended by the 2023 ACC/AHA hypertension guidelines for most patients [4].

NSAIDs including ibuprofen and naproxen blunt the antihypertensive effect of lisinopril and increase nephrotoxicity risk. Maine patients who regularly use over-the-counter NSAIDs for musculoskeletal pain should be counseled to switch to acetaminophen if possible [16].

A dry, persistent cough occurs in 5 to 20% of patients and is the most common reason for discontinuation, leading prescribers to switch to an ARB such as losartan or valsartan [16].

Cheapest Ways to Get Lisinopril in Maine: A Practical Cost Ladder

The least expensive path depends on insurance status and clinical situation. Here is a cost ladder from lowest to highest out-of-pocket expense.

$0/month. Dual-eligible Medicare/Medicaid patients, or patients who qualify for a clinic-sponsored patient assistance program using 503A compounded lisinopril.

$0, $3/month. MaineCare beneficiaries whose PA has been approved. Copay tier depends on MaineCare category.

$4, $6/month. Walmart Health Center ($4 generic program) or Costco pharmacy in Portland, Bangor, or Augusta using cash or GoodRx coupon.

$4, $9/month. Any Maine retail pharmacy (CVS, Hannaford, Rite Aid, Shaw's) with a free GoodRx, RxSaver, or NeedyMeds discount card.

$0, $10/month. Private insurance Tier 1 copay after deductible is met.

$10, $20/month. Same retail pharmacies paying cash, no coupon, after deductible period.

~$50/month. Manufacturer list price with no insurance or discount applied. No Maine patient should pay this amount; free discount cards eliminate this exposure entirely [9].

NeedyMeds maintains a database of patient assistance programs for lisinopril manufacturers that Maine patients without insurance can access at no cost [17]. Applications require proof of income (typically below 200 to 400% of the federal poverty level) and a valid prescription.

Lisinopril vs. Other ACE Inhibitors: Does the Choice Affect Maine Pricing?

Lisinopril, enalapril, ramipril, and quinapril are all ACE inhibitors available as generics in Maine. Lisinopril tends to be the least expensive of the class at most Maine retail pharmacies, partly because it has the longest generic history (since 2002) and the largest number of approved generic manufacturers [3].

Ramipril carries stronger mortality data in post-MI patients from the HOPE trial (N=9,297), which showed a 22% relative risk reduction in the primary composite endpoint at 4.5 years (P<0.001) [18]. In practice, Maine prescribers may choose ramipril for post-MI patients based on that evidence. The cash price difference between generic ramipril and generic lisinopril is small, typically $1, $3 per month, so cost is rarely the deciding factor in that comparison.

Enalapril is sometimes preferred in pediatric patients because a liquid formulation (Epaned) is FDA-approved, while lisinopril liquid must be compounded [1]. For adult hypertension without complicating factors, lisinopril and enalapril have comparable evidence and essentially equivalent pricing in Maine.

Monitoring Labs and Follow-Up Costs in Maine

The cost of lisinopril itself is only part of the total treatment cost. Baseline labs before starting and at one, three, and twelve months should include a basic metabolic panel (BMP) to monitor potassium, creatinine, and BUN. A BMP at a Maine federally qualified health center (FQHC) typically costs $15, $40 for uninsured patients on a sliding-fee scale. Insured patients pay their standard lab copay, usually $0, $20 [19].

Blood pressure monitoring at home requires a validated upper-arm device; the AHA validates specific models through the validated device listing at validatebp.org [13]. Validated monitors sell for $25, $60 at Maine pharmacies and online. A one-time investment in a validated device reduces the need for frequent office visits and lowers total care cost.

Telehealth follow-up visits in Maine for established lisinopril patients typically cost $0, $30 after insurance, compared to $75, $200 for in-person office visits at an uninsured rate.